pubmed-article:9873398 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0086574 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0007577 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C1334087 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:9873398 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
pubmed-article:9873398 | pubmed:issue | 13 | lld:pubmed |
pubmed-article:9873398 | pubmed:dateCreated | 1999-1-29 | lld:pubmed |
pubmed-article:9873398 | pubmed:abstractText | MAdCAM-1 specifically binds the lymphocyte integrin alpha 4 beta 7 and participates in the homing of leukocytes to intestinal mucosal sites. The LDT sequence located on the CD loop of MAdCAM-1 is an important binding site for MAdCAM-1/alpha 4 beta 7 interactions. N-Terminus acylation of the LDT motif and modification of the C-terminus carboxamide with amines led to low micromolar MAdCAM-1 inhibitors. | lld:pubmed |
pubmed-article:9873398 | pubmed:language | eng | lld:pubmed |
pubmed-article:9873398 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9873398 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9873398 | pubmed:month | Jul | lld:pubmed |
pubmed-article:9873398 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:SchwenderC... | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:BaxterA DAD | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:BrissieE OEO | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:PayneL JLJ | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:CochranN ANA | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:BrookfieldFF | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:ShroffH NHN | lld:pubmed |
pubmed-article:9873398 | pubmed:author | pubmed-author:GallantD LDL | lld:pubmed |
pubmed-article:9873398 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9873398 | pubmed:day | 7 | lld:pubmed |
pubmed-article:9873398 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:9873398 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9873398 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9873398 | pubmed:pagination | 1601-6 | lld:pubmed |
pubmed-article:9873398 | pubmed:dateRevised | 2005-11-21 | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:meshHeading | pubmed-meshheading:9873398-... | lld:pubmed |
pubmed-article:9873398 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9873398 | pubmed:articleTitle | Novel modified tripeptide inhibitors of alpha 4 beta 7 mediated lymphoid cell adhesion to MAdCAM-1. | lld:pubmed |
pubmed-article:9873398 | pubmed:affiliation | LeukoSite, Inc., Cambridge, MA 02142, USA. | lld:pubmed |
pubmed-article:9873398 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:9873398 | lld:chembl |
entrez-gene:3676 | entrezgene:pubmed | pubmed-article:9873398 | lld:entrezgene |
entrez-gene:8174 | entrezgene:pubmed | pubmed-article:9873398 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:9873398 | lld:entrezgene |